414 related articles for article (PubMed ID: 25524900)
1. Regulation of epithelial-mesenchymal transition through SUMOylation of transcription factors.
Bogachek MV; De Andrade JP; Weigel RJ
Cancer Res; 2015 Jan; 75(1):11-5. PubMed ID: 25524900
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis.
Neelakantan D; Drasin DJ; Ford HL
Cell Adh Migr; 2015; 9(4):265-76. PubMed ID: 25482627
[TBL] [Abstract][Full Text] [Related]
4. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
5. The epithelial to mesenchymal transition in pancreatic cancer: A systematic review.
Beuran M; Negoi I; Paun S; Ion AD; Bleotu C; Negoi RI; Hostiuc S
Pancreatology; 2015; 15(3):217-25. PubMed ID: 25794655
[TBL] [Abstract][Full Text] [Related]
6. TIF1γ protein regulates epithelial-mesenchymal transition by operating as a small ubiquitin-like modifier (SUMO) E3 ligase for the transcriptional regulator SnoN1.
Ikeuchi Y; Dadakhujaev S; Chandhoke AS; Huynh MA; Oldenborg A; Ikeuchi M; Deng L; Bennett EJ; Harper JW; Bonni A; Bonni S
J Biol Chem; 2014 Sep; 289(36):25067-78. PubMed ID: 25059663
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA control of epithelial-mesenchymal transition in cancer stem cells.
Hao J; Zhang Y; Deng M; Ye R; Zhao S; Wang Y; Li J; Zhao Z
Int J Cancer; 2014 Sep; 135(5):1019-27. PubMed ID: 24500893
[TBL] [Abstract][Full Text] [Related]
8. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
Liu X; Fan D
Curr Pharm Des; 2015; 21(10):1279-91. PubMed ID: 25506898
[TBL] [Abstract][Full Text] [Related]
9. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
Tan EJ; Olsson AK; Moustakas A
Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype.
Lee SY; Ju MK; Jeon HM; Lee YJ; Kim CH; Park HG; Han SI; Kang HS
Oxid Med Cell Longev; 2018; 2018():1027453. PubMed ID: 30671168
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression.
Ye X; Weinberg RA
Trends Cell Biol; 2015 Nov; 25(11):675-686. PubMed ID: 26437589
[TBL] [Abstract][Full Text] [Related]
12. Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer.
Alkatout I; Wiedermann M; Bauer M; Wenners A; Jonat W; Klapper W
Exp Mol Pathol; 2013 Feb; 94(1):168-73. PubMed ID: 22985790
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapy of epigenomic regulatory mechanisms controlling the epithelial to mesenchymal transition during tumor progression.
Mishra VK; Johnsen SA
Cell Tissue Res; 2014 Jun; 356(3):617-30. PubMed ID: 24833164
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin ligase Smurf2 suppresses TGFβ-induced epithelial-mesenchymal transition in a sumoylation-regulated manner.
Chandhoke AS; Karve K; Dadakhujaev S; Netherton S; Deng L; Bonni S
Cell Death Differ; 2016 May; 23(5):876-88. PubMed ID: 26679521
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
[TBL] [Abstract][Full Text] [Related]
16. Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma.
Jung CW; Han KH; Seol H; Park S; Koh JS; Lee SS; Kim MJ; Choi IJ; Myung JK
Int J Clin Exp Pathol; 2015; 8(1):560-8. PubMed ID: 25755746
[TBL] [Abstract][Full Text] [Related]
17. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma.
Chen C; Zimmermann M; Tinhofer I; Kaufmann AM; Albers AE
Cancer Lett; 2013 Sep; 338(1):47-56. PubMed ID: 22771535
[TBL] [Abstract][Full Text] [Related]
19. Snail1-driven plasticity of epithelial and mesenchymal cells sustains cancer malignancy.
Baulida J; García de Herreros A
Biochim Biophys Acta; 2015 Aug; 1856(1):55-61. PubMed ID: 26050961
[TBL] [Abstract][Full Text] [Related]
20. Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression.
Sinha D; Saha P; Samanta A; Bishayee A
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33207810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
